UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert review of anticancer therapy, 2009-04, Vol.9 (4), p.425-435

2009

Volltextzugriff (PDF)

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2016-11, Vol.375 (19), p.1823-1833

2016

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Low PD-1 Expression in Cytotoxic CD8 + Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

Clinical cancer research, 2018-01, Vol.24 (2), p.407-419

2018

Volltextzugriff (PDF)

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

The New England journal of medicine, 2023-11, Vol.389 (20), p.1839-1850

2023

Volltextzugriff (PDF)

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

The New England journal of medicine, 2023-11, Vol.389 (22), p.2039-2051

2023

Volltextzugriff (PDF)

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

Anticancer research, 2008-01, Vol.28 (1B), p.507-513

2008

Volltextzugriff (PDF)

HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis

Human pathology, 2011-06, Vol.42 (6), p.909-910

2011

Volltextzugriff (PDF)

Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer

Cancer, 2011-05, Vol.117 (9), p.1837-1846

2011

Volltextzugriff (PDF)

Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer

Clinical cancer research, 2007-11, Vol.13 (21), p.6518-6526

2007

Volltextzugriff (PDF)

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Diseases of the colon & rectum, 2020-12, Vol.63 (12), p.1602-1609

2020

Volltextzugriff (PDF)

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2

Microbiology and immunology, 2008-12, Vol.52 (12), p.575-584

2008

Volltextzugriff (PDF)

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

Cancer, 2011-05, Vol.117 (9), p.1837-1846

2011

Volltextzugriff (PDF)

Abstract 3011: Cancer of Unknown Primary: novel therapeutic opportunities from patient-derived cell cultures and in vivo models

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3011-3011

2021

Volltextzugriff (PDF)

Abstract 5432: Cancer of unknown primary site-of-origin: An enigma ready to be miR-solved

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5432-5432

2020

Volltextzugriff (PDF)

Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis

Anticancer research, 2014-06, Vol.34 (6), p.3185-3188

2014

Volltextzugriff (PDF)

Abstract 5361: Isolation and genetic characterization of circulating tumor cells from cancer of unknown primary

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5361-5361

2020

Volltextzugriff (PDF)

Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients

Clinical drug investigation, 2020-03, Vol.40 (3), p.211-226

2020

Volltextzugriff (PDF)

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter

Clinical cancer research, 2020-01, Vol.26 (2), p.518-519

2020

Volltextzugriff (PDF)

Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases

Surgery, 2018-09, Vol.164 (3), p.601-603

2018

Volltextzugriff (PDF)

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.285

2013

Volltextzugriff (PDF)

Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study

EJD. European journal of dermatology, 2017-05, Vol.27 (3), p.266-270

2017

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(73)
Berichte
(1)

Sprache

Englisch
(74)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Humans
(39)
Oncology
(26)
Female
(21)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Middle Aged
(18)
Aged
(17)
Male
(17)
Chemotherapy
(16)
Adult
(14)
Lung Neoplasms - Drug Therapy
(13)
Antineoplastic Agents
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Pharmacology. Drug Treatments
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Tumors
(9)
Antineoplastic Agents - Therapeutic Use
(8)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Low PD-1 Expression in Cytotoxic CD8 + Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

Predictive and Prognostic Significance of Neuron-specific Enolase (NSE) in Non-small Cell Lung Cancer

HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis

Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer

Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non–Small Cell Lung Cancer

Randomized Pilot Trial of Percutaneous Posterior Tibial Nerve Stimulation Versus Medical Therapy for the Treatment of Low Anterior Resection Syndrome: One-Year Follow-up

Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2

Multifactorial Central Nervous System Recurrence Susceptibility in Patients With HER2-Positive Breast Cancer: Epidemiological and Clinical Data From a Population-Based Cancer Registry Study

Abstract 3011: Cancer of Unknown Primary: novel therapeutic opportunities from patient-derived cell cultures and in vivo models

Abstract 5432: Cancer of unknown primary site-of-origin: An enigma ready to be miR-solved

Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis

Abstract 5361: Isolation and genetic characterization of circulating tumor cells from cancer of unknown primary

Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients

The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma-Letter

Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases

PD55-01 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA IN THE JAVELIN BLADDER 100 TRIAL: SUBGROUP ANALYSIS BY DURATION OF TREATMENT-FREE INTERVAL FROM END OF CHEMOTHERAPY TO START OF MAINTENANCE

Colony-stimulating factors for febrile neutropenia

Cutaneous adverse effects during ipilimumab treatment for metastatic melanoma: a prospective study

Aktive Filter

Suchergebnisse filtern